Skip to main content
NCBI home page
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Eur J Appl Physiol. 2013 May 24;113(9):2275–2283. doi: 10.1007/s00421-013-2657-0

Near-Infrared Assessments of Skeletal Muscle Oxidative Capacity in Persons With Spinal Cord Injury

Melissa Lynn Erickson 1, Terence E Ryan 1, Hui-Ju Young 1, Kevin K McCully 1
PMCID: PMC3754783  NIHMSID: NIHMS484728  PMID: 23703066

Abstract

Purpose

After spinal cord injury (SCI) skeletal muscle decreases in size, increases in intramuscular fat, and has potential declines in mitochondrial function. Reduced mitochondrial function has been linked to the development of metabolic disease. The aim of this study was to measure mitochondrial function in persons with SCI using near-infrared spectroscopy (NIRS).

Methods

Oxygen consumption of the vastus lateralis muscle was measured with NIRS during repeated short-duration arterial occlusions in nine able-bodied (AB) and nine persons with motor complete SCI. Skeletal muscle oxidative capacity (Vmax) was evaluated with two approaches: (1) rate constant of the recovery of oxygen consumption after exercise and (2) extrapolated maximum oxygen consumption from a progressive work test.

Results

Vmax as indicated by the rate constant (k) from the recovery kinetics test was lower in SCI compared to AB participants (k: SCI: 0.7 ± 0.3 vs. AB: 1.9 ± 0.4 min−1; p < 0.001). Time constants were SCI: 91.9 ± 37.8 vs. AB: 33.6 ± 8.3 sec. Vmax from the progressive work test approached a significant difference between groups (SCI: 5.1 ± 2.9 vs. AB: 9.8 ± 5.5%Hb-Mb/sec; p = 0.06).

Conclusions

NIRS measurements of Vmax suggest a deficit of 50-60% in participants with SCI compared to AB controls, consistent with previous studies using 31P-MRS and muscle biopsies. NIRS measurements can assess mitochondrial capacity in people with SCI, and potentially other injured/diseased populations.

Keywords: near-infrared spectroscopy, spinal cord injury, skeletal muscle metabolism, mitochondrial dysfunction, oxidative capacity

Introduction

Spinal cord injuries (SCI) were estimated to affect 250,000 persons in the US, including an additional 12,000 new injuries reported each year (Spinal Cord Injury: facts and figures at a glance, 2011). With improvements in medical care, all-cause cardiovascular disease has become a major health concern in persons with paraplegia (Soden RJ 2000). Diabetes is also more prevalent in people with SCI (Elder et al. 2004). Altered mitochondrial function has been associated with diabetes mellitus (Befroy et al. 2007; Anderson et al. 2009; Petersen et al. 2004). The links between mitochondrial function and disease (Ballinger 2005) support the need to assess and understand mitochondrial function in persons after SCI.

Several studies have suggested that mitochondrial function is reduced after SCI. These include ∼50% reduction of enzyme levels from muscle biopsies (Castro et al. 2000; Chilibeck et al. 1999; Martin et al. 1992). Limitations to the biopsy approach include the invasive nature of the measurement in a vulnerable population, and also enzymatic measurements may not reflect in vivo mitochondrial function. Recently, magnetic resonance spectroscopy (31P-MRS) has reported ∼ 50% reduction in the rate of phosphocreatine recovery after exercise in skeletal muscle of persons with SCI (McCully et al. 2011b). Limitations to MRS measurements include the high cost of testing, the limited number of locations that this technology is available, and the need to clear metallic implants for study in high strength magnetic fields. A more affordable and practical non-invasive measurement is needed to assess mitochondrial function after SCI.

Near-infrared spectroscopy (NIRS) is an optical method that relies on the oxygen-dependent changes in near-infrared light absorption and scattering characteristics. NIRS has been used to measure changes in skeletal muscle oxygen levels during exercise (Chance et al. 1992; Wolf et al. 2007; Hamaoka et al. 2007; Ferrari et al. 1997), skeletal muscle blood flow (van Beekvelt et al. 2001b; DeBlasi et al. 1994; Nioka et al. 2006), and skeletal muscle oxygen consumption (van Beekvelt et al. 2001b; Malagoni et al. 2010). A NIRS method has been developed that measures mitochondrial capacity by assessing the rate of recovery of oxygen consumption after exercise using multiple arterial occlusions (Motobe M 2004; Buchheit et al. 2011). This technique has recently been used in combination with a blood volume correction algorithm to improve the reliability of oxygen consumption measurements (Ryan et al. 2012a). The NIRS approach of measuring mitochondrial capacity has been used on healthy and highly trained populations (Brizendine et al. 2012), but to date has not been applied to the study of skeletal muscle from injured or diseased populations.

The purpose of the present study was to measure mitochondrial capacity in persons with SCI and able-bodied (AB) controls using NIRS. The approach used repeated cuff occlusions after exercise and the blood volume correction algorithm. We used two different approaches to evaluate mitochondrial capacity: the progressive work test and the recovery kinetics test. It was hypothesized that mitochondrial capacity would be reduced in persons with SCI when compared to AB individuals measured with NIRS, similar to previously reported MRS measurements (McCully et al. 2011a).

Methods

Study Participants

Participants with motor complete or sensory incomplete SCI as measured by the American Spinal Injury Association Impairment Scale (AIS) level A or B, were recruited for participation in this study. The recovery rate measurements include the results from 4 participants with SCI used in a previous study (Ryan et al. 2012b). AB participants, who were not performing regular moderate to high intensity exercise, as measured by the International Physical Activity Questionnaire (Maria Hagströmer 2006), were recruited as controls. The study was approved by the Institutional Review Board at the University of Georgia and by the Research Review Committee at the Shepherd Center (Atlanta, GA). We certify that all applicable instructional and governmental regulations concerning the ethical use of human volunteers were followed during the course of this research. All participants provided written informed consent prior to data collection. Data was collected from October 2011 to August 2012.

To be eligible for the study, participants with SCI had to be able to tolerate sitting upright on an exam table for 60 minutes without skin compromise or other physical problems. The exclusion criteria were as follows: those with pressure sores on the buttocks and lower extremities, those with orthopedic injuries in the lower extremities, those with a history of severe autonomic dysreflexia, and all females who were pregnant or believed they could be pregnant.

Study Design and Experimental Protocol

This was a cross-sectional study comparing persons with SCI and AB participants. Testing consisted of NIRS measurements of mitochondrial capacity in the vastus lateralis muscle.

Participants were seated upright on a padded table and remained seated upright throughout the duration of the testing session. Legs were positioned straight. The foot of the tested leg was secured in a home-built stabilization holder, which rested on the padded table. The purpose of the foot holder was to minimize motion artifact. SCI participants who did not have abdominal activation placed their hands on the table for additional stability. The NIRS probe (Oxymon MK III, Artinis Medical Systems, the Netherlands) was placed over the surface of the vastus lateralis muscle and secured on the leg with biadhesive tape and a Velcro strap. The NIRS probe, assembled with two channels, was placed approximately 10 cm proximal to the superior aspect of the patella. Both channels were place on the same anatomical location, but measured different depths of muscle tissue. NIRS data were sampled at 1000 Hz and displayed at 10 Hz. A Hokanson vascular cuff (SC 12D or SC 12L depending on leg circumference) was wrapped around the upper thigh, as high as anatomically possible, proximal to the NIRS optode. The cuff was fit to the circumference of the limb. The vascular cuff was attached to a Hokanson AG101 Rapid Cuff Inflation system (Hokanson E20 control box and AG101 compressor). During the experimental setup, the tested leg was lifted up from the table for assembly of the cuff and NIRS probe. After setup was complete, the leg was placed back on the table in a straight position. Participants were encouraged to remain as still as possible, as to avoid motion artifact during testing.

Adipose tissue overlying the muscle of interest influences NIRS measurements(van Beekvelt et al. 2001a). To control for this, adipose tissue thickness (ATT) was measured for each participant using B-Mode imaging (LOGIQ e; GE Healthcare, USA) at the start of each NIRS protocol. Based on the ATT measurement, the NIRS interoptode distance was adjusted, in order to produce optimal signal-to-noise ratio. For example, channel 1 was set at a distance approximately twice the ATT. This was done to ensure that NIRS light penetration was deep enough to reach active skeletal muscle. The second channel was always set 10 mm longer than channel 1 and this allowed for slightly deeper light penetration into the muscle.

Four homemade aluminum foil electrodes 5 × 5 cm were attached to a Theratouch 4.7 stimulator (Rich-Mar, Inola OK) and positioned over the vastus lateralis muscle as previously described(McCully et al. 2011a). Ultrasound gel was used as a conduction medium between all electrodes and the skin. Pre-wrap was used to keep electrodes in proper position. Electrical stimulation intensity (mA) for AB participants was selected based on highest tolerable current and ranged from 80 to 160 mA. This was determined individually for each participant and they were encouraged to tolerate high levels of stimulation to ensure muscle activation in the NIRS measurement site. Electrical stimulation intensity for participants with SCI was selected based on producing vigorous muscle contractions of the quadriceps muscles that visually resembled contractions of AB participants at highest tolerable currents. Electrical stimulation intensities in SCI participants ranged from 100 to 200 mA. NIRS measured recovery rates have been shown to independent of the amount of muscle activation (Ryan et al. 2012a).

NIRS Measurements

Skeletal muscle oxygen consumption (mVO2) was measured as the rate of change in muscle oxygenation during brief arterial occlusions from changes in NIRS signals using linear regression. Hemoglobin and myoglobin chromophores both contribute to changes in the NIRS signals (Lutjemeier et al. 2008). This technique assumes NIRS signal changes are proportional to mitochondrial oxygen consumption due to relative changes in hemoglobin and myoglobin saturation.

Small shifts in blood volume can occur during arterial occlusions due to blood redistribution from high to low pressure arterioles. This blood volume shift is detected by NIRS and may mask oxygen consumption measurements, leading to errors in the calculation of mVO2. In this study, the NIRS signals were corrected for this blood volume shift as previously described(Ryan et al. 2012b). The correction approach subtracts blood volume shift contributions from the NIRS signal so that changes in the oxygenated hemoglobin signal (O2HB) and changes in the deoxygenated hemoglobin signal (HHB) are symmetrical. The underlying assumption is that during arterial occlusion induces a closed system and O2Hb and HHB are stoichometrically equivalent. Each arterial occlusion was analyzed and corrected for individually.

Four resting arterial occlusions were performed (10-60 seconds) and the average of all four occlusions was used. An average of 7 seconds to 30 seconds of NIRS data from the occlusions were used, so the linear regression calculation consisted of 70-300 points.

Skeletal muscle oxidative capacity (Vmax) was determined 2 ways: with a progressive work test and a recovery kinetics test. These two approaches have been used previously to measure muscle metabolism with MRS (McCully et al. 1999). The exercise stimulus for the progressive work test and the recovery kinetics test was 15 seconds of continuous electrical stimulation. The purpose of the exercise stimulus was to activate mitochondrial respiration, and short bouts of electrical stimulation have been used previously to achieve this (Walter et al. 1997; Ryan et al. 2012b; McCully et al. 2011a). The advantage of using short duration stimulation for studying paralyzed skeletal muscle is that previous studies have shown increased fatigability and muscle damage after electrical stimulation (Slade et al. 2004; Bickel et al. 2004b; Mahoney et al. 2007).

The progressive work test was modeled after the transfer function experiments perform using MRS (Chance et al. 1985). This model assumes that ATP breakdown is tightly coupled to ATP synthesis, and that the main controlling chemical of mitochondrial oxidative phosphorylation is ADP. Thus, increasing levels of work (i.e. electrical stimulation twitch frequency) correspond directly to increasing levels of ADP. This test began with approximately 1 minute of rest followed by five 15-s bouts of electrical stimulation at the following frequencies: 2, 3, 5, 6, and 7 Hz (Pulse duration/interval = 200/50 μs) in ascending order. One minute of rest was provided between bouts of electrical stimulation. mVO2 was measured by a 10-s arterial occlusion (250-280 mmHg) performed immediately after cessation of electrical stimulation. mVO2 was calculated by applying linear regression to the linear part of the NIRS slope. The initial linear part of the slope was chosen by eye starting approximately one second into the ischemic test period. For faster metabolic rates, approximately 3 seconds were chosen so 30 points were used. For slower metabolic rates, approximately 7 seconds were chosen so 70 points were used. Motion artifact from rapid cuff inflation and deflation was avoided when selecting slopes.

Data from the progressive work test was linearized and extrapolated using the Eadie-Hofstee plot (Lehninger 1976); where mVO2 is equivalent to the velocity, and electrical stimulation frequency was used as a surrogate for substrate concentration (i.e. [ADP]). mVO2 was plotted on the x-axis and mVO2/electrical stimulation frequency was plotted on the y-axis and slope-intercept equations were determined. According to Eadie-Hofstee plot, Vmax is equal to the y intercept.

The recovery kinetics test consisted of measuring the recovery rate of mVO2 after exercise (Ryan et al. 2012b). Electrical stimulation (15 seconds at 4Hz) was used to increase mVO2. Immediately following the electrical stimulation a series of short duration cuffs (5-10 seconds) were performed as follows: cuffs 1 to 5 (5-seconds on/5-seconds off), cuffs 6 to10 (5-seconds on/10-seconds off), and cuffs 11-- (10-seconds on/20-seconds off) over 5 minutes. To accommodate for the predicted slower recovery rates of people with SCI additional cuff measurements were performed at the end of the cuff protocol described above. mVO2 for each cuff was calculated using linear regression as described above. Post-exercise mVO2 measurements were fit to an exponential curve and rate constants (Vmax) were calculated, which are proportional to mitochondrial capacity (Forbes et al. 2009; McCully et al. 1993; Richardson et al. 2002).

A physiological calibration performed and used to normalize NIRS signals for every NIRS test. The calibration provides a range of NIRS optical density unit changes, thus allowing for accurate interpretation of changes in raw NIRS data. The physiological range provides a reference point of 0% oxygen saturation in the muscle during ischemia and a reference point of 100% oxygen saturation during reactive hyperemia. Changes in NIRS signal during cuff measurements where normalized within this range and reported as %Hb-Mb/sec. The experimental procedure for the physiological calibration involved electrical stimulation for 10 seconds followed by a long duration arterial cuff occlusion (3-5 minutes) at 250-280 mmHg of pressure.

Statistical Analysis

Data are presented as means ± SD. Vmax comparisons from progressive work test and recovery kinetics test were made between AB controls and participants with SCI using a Student's unpaired t-test. Significance was accepted when p < 0.05.

Results

Nine participants with SCI and nine AB controls were tested. SCI participants varied in level of injured vertebrae, with a range of C3-T6. Injury duration ranged from 2.7-22.1 years. Average age of the SCI group was different then average age of the AB group (43.3 ± 10.7 vs. 30.9 ± 15.8 years, p < 0.05). The SCI group consisted of seven males and two females (78% male) and the AB group consisted of five males and four females (55% male). The average BMI was not different between the SCI and AB group (25.1±5.3 vs. 26.5±5.6, p = 0.96). Individual characteristics of participants with SCI are presented in Table 1. There were no adverse events during testing.

Table 1. Characteristics of Participants with SCI.

Participant Age
yrs 		BMI
Kg/m2 		ATT
cm 		Injury Level
Vertebrae Region 		Injury Duration
Yrs 		Gender
M/F
1 54 23 0.58 T6 4.5 F
2 33 34 1.2 C6-C7 5.6 F
3 58 25 0.95 T1 or T3 5.9 M
4 47 23 1.09 C3-C6 2.7 M
5 44 25 0.75 T3 22.1 M
6 26 18 0 57 T3-T5 27 M
7 46 21 141 T6 10 9 M
8 39 32 0 92 C5-C6 20 2 M
9 26 23 0 62 T1-T6 87 M
Open in a new tab

All participants were American Spinal Cord Injury Association Impairment Scale (ASI) A or B

A typical NIRS test including the progressive work test and the recovery kinetics test is shown in Figure 1. There was no difference in ATT between groups (SCI: 0.90 ± 0.30 vs. AB: 0.89 ± 0.34 cm; p = 0.96). Resting mVO2 was not different between groups (SCI: 0.45 ± 0.29 vs. AB: 0.31 ± 0.1 %Hb-Mb/sec; p = 0.14). Experimental results of the progressive work test are presented in Figure 2. During electrical stimulation, mVO2 increased proportionally with progressive increases in frequency. Average mVO2 for each electrical stimulation frequency level in both AB and SCI groups are presented in panel A of Figure 2. Vmax values from the progressive work test were extrapolated from these data using the Eadie Hofstee plot method. The average Vmax values for the SCI and AB groups approached a significant difference (SCI: 5.1 ± 2.9 vs. AB: 9.8 ± 5.5 %Hb-Mb/sec; p = 0.06). This is presented in panel B of Figure 2. The average R2 values for Eadie Hofstee plot linearization in the SCI group was 0.58 ± 0.26, ranging from 0.03 - 0.83. The average R2 value for Eadie Hofstee plot linearization in the AB group was 0.69 ± 0.28, ranging from 0.02 - 1.00.

Figure 1.

Figure 1

Open in a new tab

Representative NIRS oxygenated hemoglobin/myoglobin signal from a person with SCI during experimental protocol consisting of a 30-s resting oxygen consumption measurement, progressive work test, recovery kinetics test, and a 5-minute physiological calibration.

Figure 2.

Figure 2

Open in a new tab

Panel a shows comparisons of the SCI and AB groups during the progressive work test. Average metabolic rates for both groups at each electrical stimulation frequency are presented. Error bars represent SD. Panel b shows Eadie-Hofstee transformation of SCI and AB groups. Solid lines represent average trend lines and dashed lines represent approximate extrapolation of Vmax values. The values for Vmax are the average values calculated for each individual participant in each group.

A representative NIRS recovery kinetics test can be seen in Figure 3. Monoexponential recovery curves for an AB participant and a participant with SCI can be seen in Figure 4. On average, participants with SCI had one-third the Vmax, as indicated by the rate constant, compared to AB participants (SCI: 0.7 ± 0.3 vs. AB: 1.9 ± 0.4 min−1; p < 0.001), seen in Figure 5. The recovery time constants (1/rate constant) were 91.9 ± 37.8 sec for the SCI group and 33.6 ± 8.3 sec for the AB group. There was no difference in NIRS rate constants between channel 1 (shallow) and channel 2 (deep) in either group (AB: p = 0.76 and SCI: p = 0.76). The average R2 values for the exponential curve fit in the SCI group was 0.94 ± 0.06, ranging from 0.83 - 0.99. The average R2 values for the exponential curve fit in the AB group was 0.98 ± 0.26, ranging from 0.92 - 0.99.

Figure 3.

Figure 3

Open in a new tab

NIRS oxygenated hemoglobin/myoglobin signal during a recovery kinetics test in an able-bodied participant, consisting of 15-s of 4 Hz electrical stimulation followed by a series of short duration arterial occlusion cuffs.

Figure 4.

Figure 4

Open in a new tab

Representative NIRS recovery curves of one participant with SCI and one AB participant are presented.

Figure 5.

Figure 5

Open in a new tab

Results of NIRS recovery kinetics test comparing recovery rate constants between SCI and AB groups.

Discussion

This is the first study to systematically report NIRS measured mitochondrial capacity in persons with SCI and shows that NIRS is a feasible technique for mitochondrial assessment in a clinical population. NIRS testing can be completed in a time and cost efficient matter. This technique is non-invasive and safe for use in some vulnerable populations, as shown here in SCI. This technique can be easily exported to clinical settings and used to monitor mitochondrial responses to various pathologies or therapies.

The reported recovery rate constants extend the preliminary measurements reported in a previous study (Ryan et al. 2012b). The relative magnitude of difference in mitochondrial capacity between SCI and AB in this study is similar to the relative difference found with MRS measurements of PCr recovery (Levy et al. 1993; McCully et al. 2011a) and muscle biopsies(Martin et al. 1992). Figure 6 shows the relative differences in mitochondrial function for NIRS, MRS, and muscle biopsy techniques. Furthermore, the NIRS measured recovery time constants in this study were similar in absolute values to time constants reported for PCr recovery measurements in people with SCI (NIRS time constant = 93s in this study vs. PCr time constant = 88s previously reported)(McCully et al. 2011a). AB participants in this study had slightly faster recovery time constants (NIRS time constant = 33 s in this study vs. PCr time constant = 42 s previously reported) (McCully et al. 2011a); however, this difference does not change interpretation of the mitochondrial deficit seen in the SCI group. There was a 12-year difference in age between SCI and AB groups which may have contributed to the reported differences in mitochondrial capacity. However, the degree to which this age differences influences oxidative capacity may not be significant in this study (Larsen et al. 2012).

Figure 6.

Figure 6

Open in a new tab

Normalized mitochondrial capacity for NIRS recovery kinetics test and progressive work test. For comparison, previous studies of mitochondrial capacity using 31P-MRS(McCully et al. 2011a) and succinate dehydrogenase (SDH) activity from muscle biopsies(Martin et al. 1992). AB values were normalized to 1 and SCI values were expressed as a percentage of AB.

This study used two approaches to evaluate mitochondrial capacity (Vmax) with NIRS: the progressive work test (Argov et al. 1987; McCully et al. 1989) and the recovery kinetics test (McCully et al. 1999). These two approaches have been used previously to evaluate muscle metabolism using MRS (McCully et al. 1999). Lower mitochondrial capacity was observed in the SCI group compared to the AB group with both approaches. The progressive work test had inherently greater variability, as supported by the R2 values of the Eadie Hofstee linearization. Variability of this approach is due in part to data extrapolation and the need to accurately quantify work performed. In the present study, we could not verify that the stimulation level completely activated all the muscle tissue sampled by the NIRS device, thus some of the differences (or lack of differences) between the SCI and AB groups could be due to relative differences in the amount of muscle activated. We also used the contraction frequency as a surrogate for work performed (or time-tension integral for isometric contractions) which likely contributed to the variability. Short duration twitch stimulation was used to reduce the development of muscle damage, which as been reported in previous studies (Slade et al. 2004; Bickel et al. 2004b; Mahoney et al. 2007). Another possible factor influencing variability is that time-tension integral differs between SCI and AB (Bickel et al. 2004a; Scott et al. 2006). Nonetheless, the results of the progressive work test indicate a 52% difference in mitochondrial capacity between SCI and AB groups. This relative difference is similar to the results of the recovery kinetics test (63%). The advantage of the recovery kinetics test approach is that it does not require quantification of work, since the rate of recovery will only be influenced by muscle that has been activated (Richardson et al. 2002). Ryan et al. showed that NIRS measured recovery rates are independent of muscle activation (Ryan et al. 2012a). For this reason, potential sources of variability due to muscle activation differences are reduced in the recovery kinetics test. Another important aspect of this approach is that it requires obtaining signals fast enough to characterize the recovery rate. A key to this approach is making measurements (arterial occlusions) fast enough to capture the recovery of mVO2, which was made possible by the use of an instantaneous arterial cuff inflation device. Overall, the progressive work test is more variable then the recovery kinetics test. This may potentially limit its use in a clinical setting, where individual test results are top priority. In comparison, the recovery kinetics approach more ideal for a clinical settings due to reduce variability and shorter testing duration.

The variability of NIRS recovery rate constants in SCI was larger than AB groups, which was consistent with previous studies (McCully et al. 2011a; Martin et al. 1992). Characteristics that may have contributed to differences in variability could include injury duration, spasm activity, injury level, and physical activity. Participants with SCI tested in this study varied considerably within each of these categories, consistent with the variability reported in previous studies (McCully et al. 2011a; Martin et al. 1992). Establishing significant and meaningful relationships between the metabolic measurements and potential contributing factors will require larger sample sizes than the one in this study as well as previous studies. One advantage of the NIRS technique is that it is a portable technology that can be applied to studies with large sample sizes that may use multiple testing sites.

NIRS recovery rate constants were not different between shallow and deep channels, consistent with previous studies on AB individuals (Ryan et al. 2012b). The deeper channel is thought to obtain signals from deeper tissues and reflect a higher proportion of skeletal muscle rather than subcutaneous non-muscle tissue (van Beekvelt et al. 2001a; Chance B 2006). Due to difficulties in quantifying and comparing absolute values of signals between participants that have differing amounts of ATT and muscle, and even potential differences in heme concentrations within the muscle, the use of a physiological calibration to normalize signals is important. The lack of difference between the shallow and deep channels supports the use of a physiological calibration to compare mitochondrial measurements between different groups of participants.

Conclusion

Findings from this study support the use of NIRS measurements as a valuable technique for mitochondrial assessment in a clinical population. NIRS measured mitochondrial capacity in the SCI group had a ∼63% deficit in mitochondrial capacity compared to the AB group, consistent with previous studies that used 31P-MRS and muscle biopsies. The recovery rate approach to measuring mitochondrial capacity appeared to have less variance and to work better than the progressive work test approach. Future utilization could also involve monitoring changes in mitochondrial health in response to a drug or therapeutic intervention, which may translate to new clinical treatments.

Acknowledgments

The authors would like to thank Jared Brizendine for his assistance in data collection. Funded in part by NIH R01 HD039676. Funded in part by NIH R01 HD039676.

Abbreviations

AB

able-bodied

AIS

American Spinal Cord Injury Association Impairment Scale

ATP

adenosine triphosphate

ATT

adipose tissue thickness

MRS

magnetic Resonance Spectroscopy

mVO2

skeletal muscle oxygen consumption

NIRS

near-infrared spectroscopy

PCr

phosphocreatine

SCI

spinal cord injury

SDH

succincate dehydrogenase

Vmax

skeletal muscle oxidative capacity

31P-MRS

31-Phosphorous magnetic resonance spectroscopy

Footnotes

Conflict of Interest: The authors declare no conflicts of interest.

Contributor Information

Melissa Lynn Erickson, Email: melissa9@uga.edu.

Terence E. Ryan, Email: ryan@uga.edu.

Hui-Ju Young, Email: zoey@uga.edu.

Kevin K. McCully, Email: mccully@uga.edu.

References

  1. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW, Kang L, Rabinovitch PS, Szeto HH, Houmard JA, Cortright RN, Wasserman DH, Neufer PD. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. Journal of Clinical Investigation. 2009;119(3):573–581. doi: 10.1172/jci37048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Argov Z, Bank W, Maris J, Chance B. Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology. 1987;37:257–262. doi: 10.1212/wnl.37.2.257. [DOI] [PubMed] [Google Scholar]
  3. Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Radical Biology and Medicine. 2005;38(10):1278–1295. doi: 10.1016/j.freeradbiomed.2005.02.014. doi: http://dx.doi.org/10.1016/j.freeradbiomed.2005.02.014. [DOI] [PubMed] [Google Scholar]
  4. Befroy DE, Petersen KF, Dufour S, Mason GF, de Graaf RA, Rothman DL, Shulman GI. Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Patients. Diabetes. 2007;56(5):1376–1381. doi: 10.2337/db06-0783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bickel CS, Slade JM, Dudley GA. Long-term spinal cord injury increases susceptibility to isometric contraction-induced muscle injury. European Journal of Applied Physiology. 2004a;91(2-3):308–313. doi: 10.1007/S00421-003-0973-5. [DOI] [PubMed] [Google Scholar]
  6. Bickel CS, Slade JM, Dudley GA. Long-term spinal cord injury increases susceptibility to isometric contraction-induced muscle injury. Eur J Appl Physiol. 2004b;91(2-3):308–313. doi: 10.1007/s00421-003-0973-5. [DOI] [PubMed] [Google Scholar]
  7. Brizendine JT, Ryan TE, Larson RD, McCully KK. Skeletal Muscle Metabolism in Endurance Athletes with Near-Infrared Spectroscopy. Med Sci Sports Exerc. 2012;14:14. doi: 10.1249/MSS.0b013e31827e0eb6. [DOI] [PubMed] [Google Scholar]
  8. Buchheit M, Ufland P, Haydar B, Laursen PB, Ahmaidi S. Reproducibility and sensitivity of muscle reoxygenation and oxygen uptake recovery kinetics following running exercise in the field. Clinical Physiology and Functional Imaging. 2011;31(5):337–346. doi: 10.1111/j.1475-097X.2011.01020.x. [DOI] [PubMed] [Google Scholar]
  9. Castro MJ, Apple DF, Jr, Melton-Rogers S, Dudley GA. Muscle fiber type-specific myofibrillar Ca(2+) ATPase activity after spinal cord injury. Muscle Nerve. 2000;23(1):119–121. doi: 10.1002/(sici)1097-4598(200001)23:1<119::aid-mus17>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  10. Chance B, Dait M, Zhang C, Hamaoka T, Hagerman F. Recovery from exercise induced desaturation in the quadriceps muscles of elite competitive rowers. Am J Physiology. 1992;262:C766–C775. doi: 10.1152/ajpcell.1992.262.3.C766. [DOI] [PubMed] [Google Scholar]
  11. Chance BJI, I J, Nioka Shoko, Kushmerick M. Skeletal Muscle Energetics with PNMR: personal views and historic perspectives. NMR in Biomedicine. 2006;19(7):904–926. doi: 10.1002/nbm.1109. [DOI] [PubMed] [Google Scholar]
  12. Chance B, Leigh JS, Clark BJ, Maris J, Kent J, Nioka S, Smith D. Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. Proc Nat Acad Sci. 1985;82:8384–8388. doi: 10.1073/pnas.82.24.8384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chilibeck PD, Jeon J, Weiss C, Bell G, Burnham R. Histochemical changes in muscle of individuals with spinal cord injury following functional electrical stimulated exercise training. Spinal Cord. 1999;37(4):264–268. doi: 10.1038/sj.sc.3100785. [DOI] [PubMed] [Google Scholar]
  14. DeBlasi R, Ferrari M, Natali A, Conti G, Mega A, Gasparetto A. Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy. Journal Applied Physiology. 1994;76:1388–1393. doi: 10.1152/jappl.1994.76.3.1388. [DOI] [PubMed] [Google Scholar]
  15. Elder CP, Apple DF, Bickel CS, Meyer RA, Dudley GA. Intramuscular fat and glucose tolerance after spinal cord injury--a cross-sectional study. Spinal Cord. 2004;42(12):711–716. doi: 10.1038/sj.sc.3101652. doi:10.1038/sj.sc.3101652 3101652 [pii] [DOI] [PubMed] [Google Scholar]
  16. Ferrari M, Binzoni T, Quaresima V. Oxidative metabolism in muscle. Phil Trans R Soc Lond B. 1997;352:677–683. doi: 10.1098/rstb.1997.0049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Forbes SC, Paganini AT, Slade JM, Towse TF, Meyer RA. Phosphocreatine recovery kinetics following low- and high-intensity exercise in human triceps surae and rat posterior hindlimb muscles. Am J Physiol Regul Integr Comp Physiol. 2009;296(1):R161–170. doi: 10.1152/ajpregu.90704.2008. doi:90704.2008 [pii] 10.1152/ajpregu.90704.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hamaoka T, McCully KK, Quaresima V, Yamamoto K, Chance B. Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans. Journal of Biological Optics. 2007 doi: 10.1117/1.2805437. [DOI] [PubMed] [Google Scholar]
  19. Larsen RG, Callahan DM, Foulis SA, Kent-Braun JA. Age-related changes in oxidative capacity differ between locomotory muscles and are associated with physical activity behavior. Applied Physiology Nutrition and Metabolism-Physiologie Appliquee Nutrition Et Metabolisme. 2012;37(1):88–99. doi: 10.1139/h11-135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lehninger A. Biochemistry. 2nd. Worth Publishers, Inc.; New York: 1976. [Google Scholar]
  21. Levy M, Kushnir T, Mizrahi J, Itzchak Y. In vivo 31P NMR studies of paraplegics' muscles activated by functional electrical stimulation. Magn Reson Med. 1993;29(1):53–58. doi: 10.1002/mrm.1910290111. [DOI] [PubMed] [Google Scholar]
  22. Lutjemeier BJ, Ferreira LF, Poole DC, Townsend D, Barstow TJ. Muscle microvascular hemoglobin concentration and oxygenation within the contraction-relaxation cycle. Respir Physiol Neurobiol. 2008;160(2):131–138. doi: 10.1016/j.resp.2007.09.005. doi:S1569-9048(07)00243-1 [pii] 10.1016/j.resp.2007.09.005. [DOI] [PubMed] [Google Scholar]
  23. Mahoney E, Puetz TW, Dudley GA, McCully KK. Low-frequency fatigue in individuals with spinal cord injury. J Spinal Cord Med. 2007;30(5):458–466. doi: 10.1080/10790268.2007.11753510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Malagoni AM, Felisatti M, Mandini S, Mascoli F, Manfredini R, Basaglia N, Zamboni P, Manfredini F. Resting Muscle Oxygen Consumption by Near-Infrared Spectroscopy in Peripheral Arterial Disease: A Parameter to be Considered in a Clinical Setting? Angiology. 2010;61(6):530–536. doi: 10.1177/0003319710362975. [DOI] [PubMed] [Google Scholar]
  25. Maria Hagströmer POaMS. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutrition. 2006;9(6):755–762. doi: 10.1079/PHN2005898. [DOI] [PubMed] [Google Scholar]
  26. Martin TP, Stein RB, Hoeppner PH, Reid DC. Influence of electrical stimulation on the morphological and metabolic properties of paralyzed muscle. J Appl Physiol. 1992;72(4):1401–1406. doi: 10.1152/jappl.1992.72.4.1401. [DOI] [PubMed] [Google Scholar]
  27. McCully K, Mancini D, Levine S. Nuclear magnetic resonance spectroscopy - Its role in providing valuable insight into diverse clinical problems. Chest. 1999;116(5):1434–1441. doi: 10.1378/chest.116.5.1434. [DOI] [PubMed] [Google Scholar]
  28. McCully KK, Boden BP, Tuchler M, Fountain MR, Chance B. Wrist flexor muscles of elite rowers measured with magnetic resonance spectroscopy. Journal of Applied Physiology. 1989;67(3):926–932. doi: 10.1152/jappl.1989.67.3.926. [DOI] [PubMed] [Google Scholar]
  29. McCully KK, Fielding RA, Evans WJ, Leigh JS, Jr, Posner JD. Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles. J Appl Physiol. 1993;75(2):813–819. doi: 10.1152/jappl.1993.75.2.813. [DOI] [PubMed] [Google Scholar]
  30. McCully KK, Mulcahy TK, Ryan TE, Zhao Q. Skeletal muscle metabolism in individuals with spinal cord injury. Journal of Applied Physiology. 2011a;111(1):143–148. doi: 10.1152/japplphysiol.00094.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. McCully KK, Mulcahy TK, Ryan TE, Zhao Q. Skeletal muscle metabolism in individuals with spinal cord injury. Journal of Applied Physiology. 2011b;111(1):143–148. doi: 10.1152/japplphysiol.00094.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Motobe M, MN N, Osada T, Homma T, Uedo C, Nagasawa T, Kitahara A, Ichimura S, Kurosawa Y, Katsumura T, Hoskika A, Hamaoka T. Noninvasive monitoring of deterioration in skeletal muscle function with forearm cast immobilization and the prevention of deterioration. Dyn Med. 2004;3 doi: 10.1186/1476-5918-3-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nioka S, Kime R, Sunar U, Im J, Izzetoglu M, Zhang J, Alacam B, Chance B. A novel method to measure regional muscle blood flow continuously using NIRS kinetics information. Dynamic medicine : DM. 2006;5:5. doi: 10.1186/1476-5918-5-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes. New England Journal of Medicine. 2004;350(7):664–671. doi: 10.1056/NEJMoa031314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Richardson RS, Noyszewski EA, Haseler LJ, Bluml S, Frank LR. Evolving techniques for the investigation of muscle bioenergetics and oxygenation. Biochem Soc Trans. 2002;30(2):232–237. doi: 10.1042/. [DOI] [PubMed] [Google Scholar]
  36. Ryan TE, Brizendine JT, McCully KK. A comparison of exercise type and intensity on the noninvasive assessment of skeletal muscle mitochondrial function using near infrared spectroscopy. Journal of Applied Physiology. 2012a doi: 10.1152/japplphysiol.01043.2012. [DOI] [PubMed] [Google Scholar]
  37. Ryan TE, Erickson ML, Brizendine JT, Young HJ, McCully KK. Noninvasive evaluation of skeletal muscle mitochondrial capacity with near-infrared spectroscopy: Correcting for blood volume changes. J Appl Physiol. 2012b doi: 10.1152/japplphysiol.00319.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Scott WB, Lee SC, Johnston TE, Binkley J, Binder-Macleod SA. Contractile properties and the force-frequency relationship of the paralyzed human quadriceps femoris muscle. Phys Ther. 2006;86(6):788–799. [PubMed] [Google Scholar]
  39. Slade JM, Bickel CS, Dudley GA. The effect of a repeat bout of exercise on muscle injury in persons with spinal cord injury. Eur J Appl Physiol. 2004;92(3):363–366. doi: 10.1007/s00421-004-1103-8. [DOI] [PubMed] [Google Scholar]
  40. Soden RJ, W J, MIddleton JW, Craven ML, Rutkowski SB, Yeo JD. Causes of death after spinal cord injury. Spinal Cord. 2000;38:604–610. doi: 10.1038/sj.sc.3101080. [DOI] [PubMed] [Google Scholar]
  41. Spinal Cord Injury: facts and figures at a glance. Spinal Cord Injury Model System. 2011 doi: 10.1179/204577211X13218754005537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. van Beekvelt M, Borghuis M, van Engelen B, Wevers R, Colier W. Adipose tissue thickness affects in vivo quantitative near-IR spectroscopy in human skeletal muscle. Clin Sci (Lond) 2001a;101:21–28. doi: 10.1042/cs20000247. [DOI] [PubMed] [Google Scholar]
  43. van Beekvelt MCP, Shoemaker JK, Tschakovsky ME, Hopman MTE, Hughson R. Blood flow and muscle oxygen uptake at the onset and end of moderate and heavy dynamic forearm exercise. Am J Physiol Regulatory Integrative Comp Physiol. 2001b;280:R1741–R1747. doi: 10.1152/ajpregu.2001.280.6.R1741. [DOI] [PubMed] [Google Scholar]
  44. Walter G, Vandenborne K, McCully KK, Leigh JS. Noninvasive measurement of phosphocreatine recovery kinetics in single human muscles. Am J Physiol. 1997;272(2 Pt 1):C525–534. doi: 10.1152/ajpcell.1997.272.2.C525. [DOI] [PubMed] [Google Scholar]
  45. Wolf M, Ferrari M, Quaresima V. Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications. J Biomed Opt. 2007;12(6):062104. doi: 10.1117/1.2804899. [DOI] [PubMed] [Google Scholar]

RESOURCES